BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17187135)

  • 1. [Mitomicyn C eye drops as alternative treatment for pyogenic granuloma in anophthalmic socket].
    Santos HD; Fernandes TA; Diniz CM; Montenegro WT; Figueiredo AR
    Arq Bras Oftalmol; 2006; 69(5):683-6. PubMed ID: 17187135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of postoperative mitomycin-C eye drops on the clinical outcome in endoscopic dacryocystorhinostomy.
    Do JR; Lee H; Baek S; Lee TS; Chang M
    Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):785-90. PubMed ID: 26649433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Mitomycin C in Early Conjunctival Inflammation after Pterygium Surgery.
    da Costa Paula C; Julio G; Campos P; Pujol P; Asaad M
    Curr Eye Res; 2017 May; 42(5):696-700. PubMed ID: 27854142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed epithelial healing following photorefractive keratectomy with mitomycin C treatment.
    Kremer I; Ehrenberg M; Levinger S
    Acta Ophthalmol; 2012 May; 90(3):271-6. PubMed ID: 20456254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of double-headed pterygium surgery.
    Avisar R; Snir M; Weinberger D
    Cornea; 2003 Aug; 22(6):501-3. PubMed ID: 12883339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleral melting 16 years after pterygium excision with topical Mitomycin C adjuvant therapy.
    Wan Norliza WM; Raihan IS; Azwa JA; Ibrahim M
    Cont Lens Anterior Eye; 2006 Sep; 29(4):165-7. PubMed ID: 16938484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation.
    Thornton I; Puri A; Xu M; Krueger RR
    Am J Ophthalmol; 2007 Nov; 144(5):673-681. PubMed ID: 17889818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucous Membrane Grafting Augmented with Topical Mitomycin C Application in Contracted Socket Repair Surgeries.
    Mandour SS; Elmazar HM; Marey HM; Rahman AK; Sakr RA
    J Ocul Pharmacol Ther; 2016 Dec; 32(10):691-694. PubMed ID: 27830980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Topical Mitomycin-C Eye Drops After Reconstructive Surgery for Anophthalmic Contracted Socket.
    Mattout HK; Fouda SM; Al-Nashar HY
    Clin Ophthalmol; 2021; 15():4621-4627. PubMed ID: 34916774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of conjunctival intraepithelial neoplasia with topical drops of mitomycin C.
    Rozenman Y; Frucht-Pery J
    Cornea; 2000 Jan; 19(1):1-6. PubMed ID: 10631999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is timolol an effective treatment for pyogenic granuloma?
    Gupta D; Singh N; Thappa DM
    Int J Dermatol; 2016 May; 55(5):592-5. PubMed ID: 26872444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryotherapy in the treatment of pyogenic granuloma.
    Mirshams M; Daneshpazhooh M; Mirshekari A; Taheri A; Mansoori P; Hekmat S
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):788-90. PubMed ID: 16898898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of topical azelastine compared with topical mitomycin C in patients with allergic conjunctivitis.
    Sodhi PK; Pandey RM; Ratan SK
    Cornea; 2003 Apr; 22(3):210-3. PubMed ID: 12658084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyogenic granuloma in ten children treated with topical imiquimod.
    Tritton SM; Smith S; Wong LC; Zagarella S; Fischer G
    Pediatr Dermatol; 2009; 26(3):269-72. PubMed ID: 19706086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin C inhibits recurrent Avellino dystrophy after phototherapeutic keratectomy.
    Kim TI; Pak JH; Chae JB; Kim EK; Tchah H
    Cornea; 2006 Feb; 25(2):220-3. PubMed ID: 16371787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N
    Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia.
    Ballalai PL; Erwenne CM; Martins MC; Lowen MS; Barros JN
    Ophthalmic Plast Reconstr Surg; 2009; 25(4):296-9. PubMed ID: 19617789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subconjunctival versus intrascleral mitomycin-C in trabeculectomy.
    Tressler CS; Cyrlin MN; Rosenshein JS; Fazio R
    Ophthalmic Surg Lasers; 1996 Aug; 27(8):661-6. PubMed ID: 8858631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical mitomycin C in the treatment of pigmented conjunctival lesions.
    Rodríguez-Ares T; Touriño R; De Rojas V; Becerra E; Capeans C
    Cornea; 2003 Mar; 22(2):114-7. PubMed ID: 12605043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
    Frucht-Pery J; Sugar J; Baum J; Sutphin JE; Pe'er J; Savir H; Holland EJ; Meisler DM; Foster JA; Folberg R; Rozenman Y
    Ophthalmology; 1997 Dec; 104(12):2085-93. PubMed ID: 9400769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.